Precision medicine can help to improve existing therapies for patients with metastatic colorectal cancer


In order to implement effective treatment strategies based on precision medicine, it would be necessary to integrate all possible information on the tumour and its behaviour, from exhaustive knowledge...

Read more

New biological treatments for sinusitis with polyps

by Fundació Clínic per a la Recerca Biomèdica

Current treatments for chronic sinusitis with polyps continue to be limited. Corticosteroids and antibiotics are mainly used. In recent years, several studies have proven the effectiveness of using mo...

Read more

Observed in vivo the collective movement of nanorobots

by IBEC - Institut de Bioenginyeria de Catalunya

Observed in vivo the collective movement of nanorobots March 17, 2021 Research news A team of researchers led by Samuel Sánchez from IBEC has monitored, for the first time, the behaviour of a sw

Read more

ORYZON Launches Pioneering Schizophrenia Precision Medicine Study In Collaboration With Columbia Psychiatry

by Oryzon Genomics

Goal is to characterize the neuropsychiatric symptoms of patients harboring disease-causing SETD1A gene mutations Also includes fundamental research in preclinical SETD1A models

Read more

EuCanImage: Next-generation artificial intelligence in oncology

by Fundació Bosch i Gimpera

EuCanImage has been launched. This project from the Horizon 2020 program is coordinated by Karim Lekadir, Ramón y Cajal postdoctoral researcher at the Faculty of Mathematics and Computer Science of t...

Read more

The co-occurrence of cancer driver genes, key to precision medicine

by IRB Barcelona - Instituto de Investigación Biomédica

Cancer driver genes are those with mutations that are essential for tumour development and spread. Led by ICREA researcher Patrick Aloy, scientists from the Structural Bioinform​atics and Network Bi...

Read more

ORYZON enters into pioneering precision medicine collaboration with La Paz Hospital in Madrid for Phelan-McDermid Syndrome

by Oryzon Genomics

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...

Read more

Targeted multiplex proteomics towards more precisely matching patients to novel anti-cancer medicines


Recently published open access in Scientific Reports*, VHIO’s Paolo Nuciforo, Principal Investigator of our Molecular Oncology group, is Senior and Corresponding Author of an Article exploring the p...

Read more

The 3rd European Conference on Translational Bioinformatics brings together more than 130 experts

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

Attendees discussed the recent advances in information technologies that are facilitating translational research and precision medicine.

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...


Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

Una nueva vacuna experimental es capaz d...

by Agencia Sinc

Mejorar el diseño de las vacunas contra el cáncer es uno de los gran...

Photos Stream